Diabetic retinopathy is a complication of diabetes characterized by an extremely low rate of progression. It takes several years to move from the onset of diabetes, both type 1 and type 2, to the development of retinal microaneurysms, then leading to proliferative diabetic retinopathy and vision loss. The recent demonstration that retinal microaneurysms are preceded and, possibly, caused by a subclinical neurodegeneration mainly affecting the neurovascular unit has suggested, on one hand, the possible existence of a previously unknown early neurodegenerative stage of diabetic retinopathy and, on the other, that an early “neuroprotective” treatment could end up preventing the development of the microvascular stages. This review summarizes the present situation in the field and focuses on the prevention of diabetic retinopathy, which seems, for the first time, to be within reach.

Diabetes-Driven Retinal Neurodegeneration: Its Role in the Pathogenesis of Diabetic Retinopathy / Vigano, I., Galbiati, S., Aragona, E., Gabellini, D., Lattanzio, R., Pedon, V., Basile, G., Arrigo, A., Bandello, F., Zerbini, G.. - In: BIOMEDICINES. - ISSN 2227-9059. - 13:6(2025). [10.3390/biomedicines13061328]

Diabetes-Driven Retinal Neurodegeneration: Its Role in the Pathogenesis of Diabetic Retinopathy

Aragona E.;Arrigo A.;Bandello F.
Penultimo
;
2025-01-01

Abstract

Diabetic retinopathy is a complication of diabetes characterized by an extremely low rate of progression. It takes several years to move from the onset of diabetes, both type 1 and type 2, to the development of retinal microaneurysms, then leading to proliferative diabetic retinopathy and vision loss. The recent demonstration that retinal microaneurysms are preceded and, possibly, caused by a subclinical neurodegeneration mainly affecting the neurovascular unit has suggested, on one hand, the possible existence of a previously unknown early neurodegenerative stage of diabetic retinopathy and, on the other, that an early “neuroprotective” treatment could end up preventing the development of the microvascular stages. This review summarizes the present situation in the field and focuses on the prevention of diabetic retinopathy, which seems, for the first time, to be within reach.
2025
Inglese
Multidisciplinary Digital Publishing Institute (MDPI)
13
6
16
Pubblicato
https://www.mdpi.com/2227-9059/13/6/1328
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
diabetic retinopathy
neurodegeneration
prevention
No
Diabetes-Driven Retinal Neurodegeneration: Its Role in the Pathogenesis of Diabetic Retinopathy / Vigano, I., Galbiati, S., Aragona, E., Gabellini, D., Lattanzio, R., Pedon, V., Basile, G., Arrigo, A., Bandello, F., Zerbini, G.. - In: BIOMEDICINES. - ISSN 2227-9059. - 13:6(2025). [10.3390/biomedicines13061328]
open
10
info:eu-repo/semantics/article
262
Vigano, I.; Galbiati, S.; Aragona, E.; Gabellini, D.; Lattanzio, R.; Pedon, V.; Basile, G.; Arrigo, A.; Bandello, F.; Zerbini, G.
1 Contributo su Rivista::1.1.1 Articolo in rivista - Review
File in questo prodotto:
File Dimensione Formato  
VIGANO_ I BIOMEDICINES 2025.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 792.76 kB
Formato Adobe PDF
792.76 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/199678
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 14
social impact